Adding exercise to rosuvastatin treatment: Influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population

Metabolism: Clinical and Experimental

Volumn 59, Issue 12, 2010, Pages 1775-1783

  Coen, Paul M ^a   Flynn, Michael G ^a   Markofski, Melissa M ^a   Pence, Brandt D ^a   Hannemann, Robert E ^b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CD16 ANTIGEN; ROSUVASTATIN; TOLL LIKE RECEPTOR 4;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDURANCE TRAINING; EXERCISE; FEMALE; FITNESS; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MONOCYTE; MUSCLE STRENGTH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING;

ADULT; ANTIGENS, CD14; C-REACTIVE PROTEIN; EXERCISE; FLUOROBENZENES; GPI-LINKED PROTEINS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LONGITUDINAL STUDIES; MIDDLE AGED; MONOCYTES; PYRIMIDINES; RECEPTORS, IGG; SULFONAMIDES; TOLL-LIKE RECEPTOR 4;

EID: 78549276810     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.05.002     Document Type: Article

References (42)

1. Maron D.J., Fazio S., and Linton M.F. Current perspectives on statins Circulation 101 2000 207 213
2. Ridker P.M., Rifai N., Clearfield M., Downs J.R., Weis S.E., and Miles J.S. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 2001 1959 1965
3. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., and MacFarlane P.W. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med. 333 1995 1301 1307
4. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., and Cole T.G. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med. 335 1996 1001 1009
5. Matsumoto M., Einhaus D., Gold E.S., and Aderem A. Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors J Immunol 172 2004 7377 7384
6. Monick M.M., Powers L.S., Butler N.S., and Hunninghake G.W. Inhibition of Rho family GTPases results in increased TNF-alpha production after lipopolysaccharide exposure J Immunol 171 2003 2625 2630
7. Konat G.W., Krasowska-Zoladek A., and Kraszpulski M. Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation J Neurosci Res 86 2008 603 609
8. Helmers A.J., Gowda D.C., Kain K.C., and Liles W.C. Statins fail to improve outcome in experimental cerebral malaria and potentiate Toll-like receptor-mediated cytokine production by murine macrophages Am J Trop Med Hyg 81 2009 631 637
9. Patel T.R., and Corbett S.A. Simvastatin suppresses LPS-induced Akt phosphorylation in the human monocyte cell line THP-1 J Surg Res 116 2004 116 120
10. Hodgkinson C.P., and Ye S. Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression Pharmacogenet Genomics 18 2008 803 813
11. Hilgendorff A., Muth H., Parviz B., Staubitz A., Haberbosch W., and Tillmanns H. Statins differ in their ability to block NF-kappaB activation in human blood monocytes Int J Clin Pharmacol Ther 41 2003 397 401
12. Ferro D., Parrotto S., Basili S., Alessandri C., and Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia J Am Coll Cardiol 36 2000 427 431
13. Rezaie-Majd A., Maca T., Bucek R.A., Valent P., Muller M.R., and Husslein P. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients Arterioscler Thromb Vasc Biol 22 2002 1194 1199
14. Niessner A., Steiner S., Speidl W.S., Pleiner J., Seidinger D., and Maurer G. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo Atherosclerosis 189 2006 408 413
15. Methe H., Kim J.O., Kofler S., Nabauer M., and Weis M. Statins decrease toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes Arterioscler Thromb Vasc Biol 25 2005 1439 1445
16. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., and Chou C.J. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 2003 1821 1830
17. Hansson G.K. Inflammatory mechanisms in atherosclerosis J Thromb Haemost 7 Suppl 1 2009 328 331
18. Stewart L.K., Flynn M.G., Campbell W.W., Craig B.A., Robinson J.P., and Timmerman K.L. The influence of exercise training on inflammatory cytokines and C-reactive protein Med Sci Sports Exerc 39 2007 1714 1719
19. Timmerman K.L., Flynn M.G., Coen P.M., Markofski M.M., and Pence B.D. Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise? J Leukocyte biology 2008
20. Flynn M.G., McFarlin B.K., Phillips M.D., Stewart L.K., and Timmerman K.L. Toll-like receptor 4 and CD14 mRNA expression are lower in resistive exercise-trained elderly women J Appl Physiol 95 2003 1833 1842
21. Smith J.K., Dykes R., Douglas J.E., Krishnaswamy G., and Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease Jama 281 1999 1722 1727
22. McFarlin B.K., Flynn M.G., Campbell W.W., Stewart L.K., and Timmerman K.L. TLR4 is lower in resistance-trained older women and related to inflammatory cytokines Med Sci Sports Exerc 36 2004 1876 1883
23. Stewart L.K., Flynn M.G., Campbell W.W., Craig B.A., Robinson J.P., and McFarlin B.K. Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4 Brain Behav Immun 19 2005 389 397
24. Troseid M., Lappegard K.T., Claudi T., Damas J.K., Morkrid L., and Brendberg R. Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome Eur Heart J 25 2004 349 355
25. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
26. ACSM, Kenney W.L., Humphrey R.H., Bryant C.X., and Mahler D.A. ACSM's guidelines for exercise testing and prescription 5th ed 1995 Williams and Wilkins Baltimore (Md)
27. Paffenbarger R.S. Jr., Blair S.N., Lee I.M., and Hyde R.T. Measurement of physical activity to assess health effects in free-living populations Med Sci Sports Exerc 25 1993 60 70
28. NCEP Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
29. McFarlin B.K., Flynn M.G., Campbell W.W., Craig B.A., Robinson J.P., and Stewart L.K. Physical activity status, but not age, influences inflammatory biomarkers and toll-like receptor 4 J Gerontol A Biol Sci Med Sci 61 2006 388 393
30. Skinner N.A., MacIsaac C.M., Hamilton J.A., and Visvanathan K. Regulation of toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens Clin Exp Immunol 141 2005 270 278
31. Frankenberger M., Sternsdorf T., Pechumer H., Pforte A., and Ziegler-Heitbrock H.W. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis Blood 87 1996 373 377
32. Belge K.U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., and Frankenberger B. The proinflammatory CD14+CD16+DR+ monocytes are a major source of TNF J Immunol 168 2002 3536 3542
33. Baeten D., Boots A.M., Steenbakkers P.G., Elewaut D., Bos E., and Verheijden G.F. Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis Arthritis Rheum 43 2000 1233 1243
34. Schlitt A., Heine G.H., Blankenberg S., Espinola-Klein C., Dopheide J.F., and Bickel C. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels Thromb Haemost 92 2004 419 424
35. Nikolic T., Bouma G., Drexhage H.A., and Leenen P.J. Diabetes-prone NOD mice show an expanded subpopulation of mature circulating monocytes, which preferentially develop into macrophage-like cells in vitro J Leukoc Biol 78 2005 70 79
36. Ancuta P., Rao R., Moses A., Mehle A., Shaw S.K., and Luscinskas F.W. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes J Exp Med 197 2003 1701 1707
37. Hakkinen T., Karkola K., and Yla-Herttuala S. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII) Virchows Arch 437 2000 396 405
38. Randolph G.J., Sanchez-Schmitz G., Liebman R.M., and Schakel K. The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting J Exp Med 196 2002 517 527
39. Libby P. Inflammation in atherosclerosis Nature 420 2002 868 874
40. Ferdinand K.C., Clark L.T., Watson K.E., Neal R.C., Brown C.D., and Kong B.W. Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial Am J Cardiol 97 2006 229 235
41. Rogers A., and Eastell R. The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood Bone 29 2001 30 34
42. Schuurs A.H., and Verheul H.A. Effects of gender and sex steroids on the immune response J Steroid Biochem 35 1990 157 172